Insulin resistance, hypertension, and coronary heart disease
1Stanford University School of Medicine, Stanford Medical Center, 300 Pasteur Drive, Stanford, CA 94305-5406, USA. greaven@cvmed.stanford.edu
Abstract:
The goals of this review are two-fold: to examine the evidence in support of a role for insulin resistance and compensatory hyperinsulinemia in the pathogenesis of essential hypertension, and to evaluate the hypothesis that insulin resistance and its manifestations play major roles in the development of coronary heart disease in patients with essential hypertension. In both instances, only experimental results in human beings will be considered. Although it remains a scientific issue of great importance, the scope of this review precludes a discussion of the mechanistic link between insulin resistance/hyperinsulinemia and essential hypertension.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology


